Borderline ovarian tumours: A comprehensive review of published evidence.
1/5 보강
Borderline Ovarian Tumours (BOTs) comprise 15-20 % of all epithelial ovarian tumours.
APA
Papalois KB, Sideris M, et al. (2026). Borderline ovarian tumours: A comprehensive review of published evidence.. Best practice & research. Clinical obstetrics & gynaecology, 104, 102688. https://doi.org/10.1016/j.bpobgyn.2025.102688
MLA
Papalois KB, et al.. "Borderline ovarian tumours: A comprehensive review of published evidence.." Best practice & research. Clinical obstetrics & gynaecology, vol. 104, 2026, pp. 102688.
PMID
41349280 ↗
Abstract 한글 요약
Borderline Ovarian Tumours (BOTs) comprise 15-20 % of all epithelial ovarian tumours. BOTs are characterised by increased mitotic activity but lack infiltrative destructive growth and stromal invasion. Several dilemmas and controversies have been discussed in the literature regarding BOT management including surgical approach (radical versus fertility-sparing surgery), surgical route (open versus laparoscopic surgery) and impact on disease recurrence, follow-up protocols/modalities (imaging, serum biomarkers), role of completion surgery, lymph node dissection during staging, adjuvant chemotherapy, as well as use of Hormone-Replacement Therapy (HRT) post-surgery. We performed a structured narrative review on Medline and Cochrane Library Databases to identify studies pertaining to the management of BOTs. Identifying areas of agreement and outstanding uncertainty are integral to optimise robust treatment regimens for BOT management and improve the Quality of Life (QoL) and clinical outcomes for patients. We discuss a framework of recommendations to counsel, manage and follow-up women diagnosed with BOT.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Female
- Ovarian Neoplasms
- Carcinoma
- Ovarian Epithelial
- Fertility Preservation
- Chemotherapy
- Adjuvant
- Quality of Life
- Lymph Node Excision
- Laparoscopy
- Neoplasm Staging
- Neoplasm Recurrence
- Local
- Borderline ovarian tumours
- Patient follow-up
- Quality of life
- Risk of malignancy
- Treatment guidelines
- Treatment modality
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.